June 28, 2011

ST JUDE: Cooperating with US FDA to Resolve Epicor Concerns

COMPANIES: St Jude Medical Inc

Subscribe

St. Jude Medical, Inc. disclosed in its latest quarterly report on

Form 10-Q filed with the U.S. Securities and Exchange Commission

that the Company is working cooperatively with the U.S. Food and

Drug Administration (FDA) to resolve Epicor LP Cardiac Ablation

System and the…

TO CONTINUE READING,LOGIN or

TOPICS: Earnings | Legal Issues, Litigation | Loans & Financing | Medical Supplies | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US

LOCATIONS: California | United States